TIPE3 Protein Promotes Breast Cancer Metastasis Through Activating AKT and NF-κB Signaling Pathways

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Apr 8

PMID 28388580

Citations 12

Authors

Kaili Lian

Chao Ma

Chunyan Hao

Yan Li

Na Zhang

Youhai H Chen

Suxia Liu

Affiliations

Soon will be listed here.

Abstract

TIPE3 (TNFAIP8L3) is the transfer protein of phosphoinositide second messengers that promote cancer. Its role in breast cancer has not been evaluated. We report here that TIPE3 protein was significantly upregulated in human breast cancer tissues as compared with adjacent non-tumor tissues from the same patients. The level of TIPE3 protein in invasive ductal carcinoma was significant higher than that in ductal carcinoma in situ (DCIS), and the level of TIPE3 in lymphatic metastasized carcinoma was higher than that in invasive ductal carcinoma from the same patients. Additionally, the level of TIPE3 protein was positively correlated with the level of human epidermal growth factor receptor 2 (HER-2), and TIPE3 expression was significantly higher in high-invasive breast cancer cell lines than that in low-invasive cell lines. Importantly, TIPE3 knockdown in breast cancer cells inhibited cell proliferation, migration, and invasion in vitro, whereas TIPE3 overexpression had the opposite effect. In mice, TIPE3 expression significantly promoted the metastasis of breast cancer cells. TIPE3 expression also increased the level of MMP2 and uPA, and the activation of the AKT and NF-κB signaling pathways. These results demonstrate that TIPE3 may promote breast cancer growth and metastasis through AKT and NF-κB, and may serve as a potential biomarker for breast cancer metastasis.

Citing Articles

MTA2 knockdown suppresses human osteosarcoma metastasis by inhibiting uPA expression.

Tseng C, Chen C, Hsieh Y, Lin C, Chen J, Hsiao P Aging (Albany NY). 2024; 16(17):12239-12251.

PMID: 39248711 PMC: 11424574. DOI: 10.18632/aging.206070.

Small-Molecule Inhibitors of TIPE3 Protein Identified through Deep Learning Suppress Cancer Cell Growth In Vitro.

Chen X, Lu Z, Xiao J, Xia W, Pan Y, Xia H Cells. 2024; 13(9.

PMID: 38727307 PMC: 11082981. DOI: 10.3390/cells13090771.

Establishment of a prognostic model for ovarian cancer based on mitochondrial metabolism-related genes.

Meng C, Sun Y, Liu G Front Oncol. 2023; 13:1144430.

PMID: 37256178 PMC: 10226651. DOI: 10.3389/fonc.2023.1144430.

TIPE3 represses head and neck squamous cell carcinoma progression via triggering PGAM5 mediated mitochondria dysfunction.

Chen W, Chen X, Wang L, Yang R, Zhang W, Zhang S Cell Death Dis. 2023; 14(4):251.

PMID: 37024453 PMC: 10079926. DOI: 10.1038/s41419-023-05775-3.

Tumor necrosis factor-α-inducible protein 8-like protein 3 (TIPE3): a novel prognostic factor in colorectal cancer.

Xu Y, Zhu Y, Xia H, Wang Y, Li L, Wan H BMC Cancer. 2023; 23(1):131.

PMID: 36755222 PMC: 9909977. DOI: 10.1186/s12885-023-10590-2.

References

Porturas T, Sun H, Buchlis G, Lou Y, Liang X, Cathopoulis T . Crucial roles of TNFAIP8 protein in regulating apoptosis and Listeria infection. J Immunol. 2015; 194(12):5743-50. PMC: 4458408. DOI: 10.4049/jimmunol.1401987. View

Cui J, Hao C, Zhang W, Shao J, Zhang N, Zhang G . Identical expression profiling of human and murine TIPE3 protein reveals links to its functions. J Histochem Cytochem. 2014; 63(3):206-16. PMC: 4340736. DOI: 10.1369/0022155414564871. View

Galluzzi L, Kroemer G . Necroptosis: a specialized pathway of programmed necrosis. Cell. 2008; 135(7):1161-3. DOI: 10.1016/j.cell.2008.12.004. View

Sun H, Gong S, Carmody R, Hilliard A, Li L, Sun J . TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell. 2008; 133(3):415-26. PMC: 2398615. DOI: 10.1016/j.cell.2008.03.026. View

Lv H, Li Y, Du H, Fang J, Song X, Zhang J . The Synthetic Compound Norcantharidin Induced Apoptosis in Mantle Cell Lymphoma In Vivo and In Vitro through the PI3K-Akt-NF- κ B Signaling Pathway. Evid Based Complement Alternat Med. 2013; 2013:461487. PMC: 3722980. DOI: 10.1155/2013/461487. View

Fan L, Strasser-Weippl K, Li J, St Louis J, Finkelstein D, Yu K . Breast cancer in China. Lancet Oncol. 2014; 15(7):e279-89. DOI: 10.1016/S1470-2045(13)70567-9. View

Cao X, Zhang L, Shi Y, Sun Y, Dai S, Guo C . Human tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1. Mol Cancer. 2013; 12(1):149. PMC: 4176125. DOI: 10.1186/1476-4598-12-149. View

Freundt E, Bidere N, Lenardo M . A different TIPE of immune homeostasis. Cell. 2008; 133(3):401-2. PMC: 2750003. DOI: 10.1016/j.cell.2008.04.017. View

Shaw J, Stebbing J . Circulating free DNA in the management of breast cancer. Ann Transl Med. 2014; 2(1):3. PMC: 4200656. DOI: 10.3978/j.issn.2305-5839.2013.06.06. View

10.

Moirangthem A, Bondhopadhyay B, Mukherjee M, Bandyopadhyay A, Mukherjee N, Konar K . Simultaneous knockdown of uPA and MMP9 can reduce breast cancer progression by increasing cell-cell adhesion and modulating EMT genes. Sci Rep. 2016; 6:21903. PMC: 4764826. DOI: 10.1038/srep21903. View

11.

Hitomi J, Christofferson D, Ng A, Yao J, Degterev A, Xavier R . Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell. 2008; 135(7):1311-23. PMC: 2621059. DOI: 10.1016/j.cell.2008.10.044. View

12.

Slamon D, Clark G, Wong S, Levin W, Ullrich A, McGuire W . Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987; 235(4785):177-82. DOI: 10.1126/science.3798106. View

13.

Luan Y, Yao Y, Sheng Z . The tumor necrosis factor-alpha-induced protein 8 family in immune homeostasis and inflammatory cancer diseases. J Biol Regul Homeost Agents. 2013; 27(3):611-9. View

14.

Zhang W, Zhang J, Zhao L, Shao J, Cui J, Guo C . TIPE2 protein negatively regulates HBV-specific CD8⁺ T lymphocyte functions in humans. Mol Immunol. 2014; 64(1):204-9. DOI: 10.1016/j.molimm.2014.11.019. View

15.

Piao H, Yuan Y, Wang M, Sun Y, Liang H, Ma L . α-catenin acts as a tumour suppressor in E-cadherin-negative basal-like breast cancer by inhibiting NF-κB signalling. Nat Cell Biol. 2014; 16(3):245-54. PMC: 3943677. DOI: 10.1038/ncb2909. View

16.

Paterson M, Dietrich K, Danyluk J, Paterson A, Lees A, Jamil N . Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res. 1991; 51(2):556-67. View

17.

Fayngerts S, Wu J, Oxley C, Liu X, Vourekas A, Cathopoulis T . TIPE3 is the transfer protein of lipid second messengers that promote cancer. Cancer Cell. 2014; 26(4):465-78. PMC: 4198483. DOI: 10.1016/j.ccr.2014.07.025. View

18.

Peng Y, Zhao Q, Zhang H, Han B, Liu S, Han M . TIPE2, a negative regulator of TLR signaling, regulates p27 through IRF4-induced signaling. Oncol Rep. 2016; 35(4):2480-6. DOI: 10.3892/or.2016.4562. View

19.

Natarajan K, Singh S, Burke Jr T, Grunberger D, Aggarwal B . Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci U S A. 1996; 93(17):9090-5. PMC: 38600. DOI: 10.1073/pnas.93.17.9090. View

20.

Lee J, Park K, Lee E, Ahn T, Jung H, Lim S . Gene Expression Profiling of Breast Cancer Brain Metastasis. Sci Rep. 2016; 6:28623. PMC: 4919653. DOI: 10.1038/srep28623. View